CAPN1 and Alzheimer disease: Our results, using APP/PS1 mice, a widely used mouse model of AD, suggest that at least in the early stage of AD pathogenesis, calpain-2 but not calpain-1 dysregulation is localized to synapses and is not seen in brain lysates.